[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE69023459D1 - Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten. - Google Patents

Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.

Info

Publication number
DE69023459D1
DE69023459D1 DE69023459T DE69023459T DE69023459D1 DE 69023459 D1 DE69023459 D1 DE 69023459D1 DE 69023459 T DE69023459 T DE 69023459T DE 69023459 T DE69023459 T DE 69023459T DE 69023459 D1 DE69023459 D1 DE 69023459D1
Authority
DE
Germany
Prior art keywords
treatment
keto
pulmonary dysfunction
prostaglandin derivatives
dysfunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69023459T
Other languages
English (en)
Other versions
DE69023459T2 (de
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of DE69023459D1 publication Critical patent/DE69023459D1/de
Application granted granted Critical
Publication of DE69023459T2 publication Critical patent/DE69023459T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69023459T 1989-11-22 1990-11-21 Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten. Expired - Lifetime DE69023459T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30384189 1989-11-22

Publications (2)

Publication Number Publication Date
DE69023459D1 true DE69023459D1 (de) 1995-12-14
DE69023459T2 DE69023459T2 (de) 1996-04-04

Family

ID=17925951

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69023459T Expired - Lifetime DE69023459T2 (de) 1989-11-22 1990-11-21 Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.

Country Status (5)

Country Link
EP (1) EP0430552B1 (de)
KR (1) KR0153779B1 (de)
AT (1) ATE129895T1 (de)
CA (1) CA2030344C (de)
DE (1) DE69023459T2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0978284T3 (da) * 1997-11-28 2008-10-27 Sucampo Ag Anvendelse af 15-keto-prostaglandin-E-forbindelser som endothelinantagonister
EP1220849B1 (de) 1999-10-15 2004-05-19 Sucampo AG Bizyclische verbindungen zusammenstellung und verfahren zu ihrer stabilisierung
MXPA04002006A (es) 2001-08-31 2004-06-07 Sucampo Ag Analogos de prostagladina como abridor del canal de cloruro.
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
WO2007102446A2 (en) * 2006-02-28 2007-09-13 Sucampo Ag Method and composition for treating chronic obstructive pulmonary disease
US8569279B2 (en) 2009-05-27 2013-10-29 Sucampo Ag Method for modulating claudin mediated functions
BRPI1011658A2 (pt) * 2009-05-27 2018-03-06 Univ Osaka composição farmacêutica que compreende derivado de prostaglandina para uso na modulação das funções medianas por claudina e no tratamento de distúrbios dermatológicos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3764699A (en) * 1971-12-02 1973-10-09 American Home Prod Methods for relieving bronchial spasm with prostaglandin-f{11 and derivatives
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS58164512A (ja) 1982-03-25 1983-09-29 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤
JPS5973522A (ja) 1982-10-20 1984-04-25 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
JPS58203911A (ja) 1982-05-25 1983-11-28 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物を有効成分として含有する細肪障害治療剤
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
ATE78465T1 (de) 1987-10-02 1992-08-15 Ueno Seiyaku Oyo Kenkyujo Kk Kathartica.
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
EP0343904B1 (de) * 1988-05-23 1993-04-28 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Hypersphyxia verursachende Zusammensetzung
DE69025787T2 (de) * 1989-04-04 1996-10-31 Beiersdorf Ag Mittel zur Atopieprophylaxe

Also Published As

Publication number Publication date
EP0430552B1 (de) 1995-11-08
EP0430552A2 (de) 1991-06-05
KR0153779B1 (ko) 1998-11-16
KR910009271A (ko) 1991-06-28
CA2030344A1 (en) 1991-05-23
DE69023459T2 (de) 1996-04-04
EP0430552A3 (en) 1992-07-01
CA2030344C (en) 2000-04-18
ATE129895T1 (de) 1995-11-15

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
ATE137116T1 (de) Behandlung von entzündlichen erkrankungen mit 15- ketoprostaglandinen
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE3886959D1 (de) 1,2-Propandiolderivate.
NO881768L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner.
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
DE69006964D1 (de) Behandlung von Hyperlipidemia mit 15-keto-Prostaglandin-Verbindungen.
ATE90565T1 (de) Behandlung des schocks mit cyclodextrin und dessen derivaten.
DE68906028D1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
NO912745D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,5,6-tetrahydropyridinforbindelser.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH